Style | Citing Format |
---|---|
MLA | Yazdanpanah MH, et al.. "The Best Qt Correction Formula in a Non-Hospitalized Population: The Fasa Persian Cohort Study." BMC Cardiovascular Disorders, vol. 22, no. 1, 2022, pp. -. |
APA | Yazdanpanah MH, Naghizadeh MM, Sayyadipoor S, Farjam M (2022). The Best Qt Correction Formula in a Non-Hospitalized Population: The Fasa Persian Cohort Study. BMC Cardiovascular Disorders, 22(1), -. |
Chicago | Yazdanpanah MH, Naghizadeh MM, Sayyadipoor S, Farjam M. "The Best Qt Correction Formula in a Non-Hospitalized Population: The Fasa Persian Cohort Study." BMC Cardiovascular Disorders 22, no. 1 (2022): -. |
Harvard | Yazdanpanah MH et al. (2022) 'The Best Qt Correction Formula in a Non-Hospitalized Population: The Fasa Persian Cohort Study', BMC Cardiovascular Disorders, 22(1), pp. -. |
Vancouver | Yazdanpanah MH, Naghizadeh MM, Sayyadipoor S, Farjam M. The Best Qt Correction Formula in a Non-Hospitalized Population: The Fasa Persian Cohort Study. BMC Cardiovascular Disorders. 2022;22(1):-. |
BibTex | @article{ author = {Yazdanpanah MH and Naghizadeh MM and Sayyadipoor S and Farjam M}, title = {The Best Qt Correction Formula in a Non-Hospitalized Population: The Fasa Persian Cohort Study}, journal = {BMC Cardiovascular Disorders}, volume = {22}, number = {1}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Yazdanpanah MH AU - Naghizadeh MM AU - Sayyadipoor S AU - Farjam M TI - The Best Qt Correction Formula in a Non-Hospitalized Population: The Fasa Persian Cohort Study JO - BMC Cardiovascular Disorders VL - 22 IS - 1 SP - EP - PY - 2022 ER - |